RE:RE:ValuationsVery shortsighted to think the current number of MM patients presently in Canada will stay stagnant at “42000ish”. Right now we are in the very early stages of an emerging industry that will drastically change how people deal with pain. And pain relief is a multi billion-dollar industry that will continue to expand exponentially because of the aging boomer population. Bedrocan, given the quality and consistency of their pharmacy grade CBD strains, will be at the forefront of this expansion. Unfortunately all physician organizations, including the Canadian Medical Assoc. and the Royal College of Physicians and Surgeons, have urged their members not to prescribe cannabis until an authoritative Canadian case study can prove its efficacy and establish dosing standards. Well, the study has been started and the revolution is coming.